T1	AdverseReaction 89 118	elevated intraocular pressure
T2	DrugClass 61 80	ophthalmic steroids
T3	AdverseReaction 149 167	optic nerve damage
T4	AdverseReaction 169 182;193 200	visual acuity defects
T5	AdverseReaction 169 175;187 200	visual field defects
T6	AdverseReaction 202 242	posterior subcapsular cataract formation
T7	AdverseReaction 244 270	secondary ocular infection
T8	AdverseReaction 244 270;296 310	secondary ocular infection herpes simplex
T9	AdverseReaction 316 340	perforation of the globe
T10	AdverseReaction 516 529	corneal edema
T11	AdverseReaction 531 538;556 565	ciliary hyperemia
T12	AdverseReaction 543 565	conjunctival hyperemia
T13	AdverseReaction 567 575	eye pain
T14	AdverseReaction 577 588	photophobia
T15	AdverseReaction 590 621	posterior capsule opacification
T16	AdverseReaction 623 645	anterior chamber cells
T17	AdverseReaction 647 669	anterior chamber flare
T18	AdverseReaction 671 689	conjunctival edema
T19	AdverseReaction 695 706	blepharitis
T20	AdverseReaction 779 800	reduced visual acuity
T21	AdverseReaction 802 820	punctate keratitis
T22	AdverseReaction 822 838	eye inflammation
T23	AdverseReaction 844 850	iritis
T24	AdverseReaction 917 944	application site discomfort
T25	AdverseReaction 917 933;948 958	application site irritation
T26	AdverseReaction 960 980	corneal pigmentation
T27	AdverseReaction 960 967;985 991	corneal striae
T28	AdverseReaction 993 1005	episcleritis
T29	AdverseReaction 1007 1019	eye pruritis
T30	AdverseReaction 1021 1038	eyelid irritation
T31	AdverseReaction 1021 1027;1043 1051	eyelid crusting
T32	AdverseReaction 1053 1075	foreign body sensation
T33	AdverseReaction 1077 1098	increased lacrimation
T34	AdverseReaction 1100 1113	macular edema
T35	AdverseReaction 1115 1131	sclera hyperemia
T36	AdverseReaction 1137 1144	uveitis
T37	AdverseReaction 1503 1517	blurred vision
T38	AdverseReaction 1519 1533	eye irritation
T39	AdverseReaction 1535 1543	eye pain
T40	AdverseReaction 1545 1553	headache
T41	AdverseReaction 1555 1568	increased IOP
T42	AdverseReaction 1570 1576	iritis
T43	AdverseReaction 1578 1584;1602 1611	limbal hyperemia
T44	AdverseReaction 1589 1611	conjunctival hyperemia
T45	AdverseReaction 1613 1631	punctate keratitis
T46	AdverseReaction 1637 1644	uveitis
T47	AdverseReaction 1704 1726	anterior chamber flare
T48	AdverseReaction 1728 1741	corneal edema
T49	AdverseReaction 1743 1750	dry eye
T50	AdverseReaction 1752 1765	iridocyclitis
T51	AdverseReaction 1767 1778	photophobia
T52	AdverseReaction 1784 1805	reduced visual acuity
T53	AdverseReaction 418 442	Ocular adverse reactions
E1	AdverseReaction:T1 Hypothetical:E2
E2	DrugClass:T2
E3	AdverseReaction:T3 Hypothetical:E2
E4	AdverseReaction:T4 Hypothetical:E2
E5	AdverseReaction:T5 Hypothetical:E2
E6	AdverseReaction:T6 Hypothetical:E2
E7	AdverseReaction:T7 Hypothetical:E2
E8	AdverseReaction:T8 Hypothetical:E2
E9	AdverseReaction:T9 Hypothetical:E2
E10	AdverseReaction:T10
E11	AdverseReaction:T11
E12	AdverseReaction:T12
E13	AdverseReaction:T13
E14	AdverseReaction:T14
E15	AdverseReaction:T15
E16	AdverseReaction:T16
E17	AdverseReaction:T17
E18	AdverseReaction:T18
E19	AdverseReaction:T19
E20	AdverseReaction:T20
E21	AdverseReaction:T21
E22	AdverseReaction:T22
E23	AdverseReaction:T23
E24	AdverseReaction:T24
E25	AdverseReaction:T25
E26	AdverseReaction:T26
E27	AdverseReaction:T27
E28	AdverseReaction:T28
E29	AdverseReaction:T29
E30	AdverseReaction:T30
E31	AdverseReaction:T31
E32	AdverseReaction:T32
E33	AdverseReaction:T33
E34	AdverseReaction:T34
E35	AdverseReaction:T35
E36	AdverseReaction:T36
E37	AdverseReaction:T37
E38	AdverseReaction:T38
E39	AdverseReaction:T39
E40	AdverseReaction:T40
E41	AdverseReaction:T41
E42	AdverseReaction:T42
E43	AdverseReaction:T43
E44	AdverseReaction:T44
E45	AdverseReaction:T45
E46	AdverseReaction:T46
E47	AdverseReaction:T47
E48	AdverseReaction:T48
E49	AdverseReaction:T49
E50	AdverseReaction:T50
E51	AdverseReaction:T51
E52	AdverseReaction:T52
E53	AdverseReaction:T53
A1	CUI E1 C0234708
A2	UMLS-Preferred-Name E1 Raised intraocular pressure
A3	MEDDRA-PT E1 Intraocular pressure increased
A4	MEDDRA-PT-ID E1 10022806
A5	LLT E1 Increased intraocular pressure
A6	LLT-ID E1 10021667
A7	CUI E3 C0161398
A8	UMLS-Preferred-Name E3 Optic Nerve Injuries
A9	MEDDRA-PT E3 Optic nerve injury
A10	MEDDRA-PT-ID E3 10030938
A11	LLT E3 Optic nerve damage
A12	LLT-ID E3 10075452
A13	CUI E4 C0234632
A14	UMLS-Preferred-Name E4 Reduced visual acuity
A15	MEDDRA-PT E4 Visual acuity reduced
A16	MEDDRA-PT-ID E4 10047531
A17	CUI E5 C3887875
A18	UMLS-Preferred-Name E5 Visual field defects
A19	MEDDRA-PT E5 Visual field defect
A20	MEDDRA-PT-ID E5 10047555
A21	CUI E6 C0858617
A22	UMLS-Preferred-Name E6 Posterior subcapsular cataract
A23	MEDDRA-PT E6 Cataract subcapsular
A24	MEDDRA-PT-ID E6 10007764
A25	LLT E6 Posterior subcapsular cataract
A26	LLT-ID E6 10036364
A27	CUI E7 C0015403
A28	UMLS-Preferred-Name E7 Eye Infections
A29	MEDDRA-PT E7 Eye infection
A30	MEDDRA-PT-ID E7 10015929
A31	CUI E8 C0494081
A32	UMLS-Preferred-Name E8 Herpesviral ocular disease
A33	MEDDRA-PT E8 Ophthalmic herpes simplex
A34	MEDDRA-PT-ID E8 10073938
A35	CUI E9 C0860533
A36	UMLS-Preferred-Name E9 Rupture of globe due to trauma
A37	MEDDRA-PT E9 Open globe injury
A38	MEDDRA-PT-ID E9 10076717
A39	LLT E9 Ocular perforation
A40	LLT-ID E9 10030062
A41	CUI E10 C0010037
A42	UMLS-Preferred-Name E10 Corneal edema
A43	MEDDRA-PT E10 Corneal oedema
A44	MEDDRA-PT-ID E10 10011033
A45	LLT E10 Corneal edema
A46	LLT-ID E10 10011007
A47	CUI E11 C0948784
A48	UMLS-Preferred-Name E11 Ciliary hyperaemia
A49	MEDDRA-PT E11 Ciliary hyperaemia
A50	MEDDRA-PT-ID E11 10052129
A51	LLT E11 Ciliary hyperemia
A52	LLT-ID E11 10054354
A53	CUI E12 C1761613
A54	UMLS-Preferred-Name E12 Conjunctival hyperemia
A55	MEDDRA-PT E12 Conjunctival hyperaemia
A56	MEDDRA-PT-ID E12 10051625
A57	LLT E12 Conjunctival hyperemia
A58	LLT-ID E12 10054364
A59	CUI E13 C0151827
A60	UMLS-Preferred-Name E13 Eye pain
A61	MEDDRA-PT E13 Eye pain
A62	MEDDRA-PT-ID E13 10015958
A63	CUI E14 C0085636
A64	UMLS-Preferred-Name E14 Photophobia
A65	MEDDRA-PT E14 Photophobia
A66	MEDDRA-PT-ID E14 10034960
A67	CUI E15 C1444680
A68	UMLS-Preferred-Name E15 Posterior capsule opacification
A69	MEDDRA-PT E15 Posterior capsule opacification
A70	MEDDRA-PT-ID E15 10036346
A71	CUI E16 C0423282
A72	UMLS-Preferred-Name E16 Anterior chamber cells
A73	MEDDRA-PT E16 Anterior chamber cell
A74	MEDDRA-PT-ID E16 10053781
A75	CUI E17 C0423281
A76	UMLS-Preferred-Name E17 Anterior chamber flare
A77	MEDDRA-PT E17 Anterior chamber flare
A78	MEDDRA-PT-ID E17 10052127
A79	CUI E18 C0151601
A80	UMLS-Preferred-Name E18 Conjunctival edema
A81	MEDDRA-PT E18 Conjunctival oedema
A82	MEDDRA-PT-ID E18 10010726
A83	LLT E18 Conjunctival edema
A84	LLT-ID E18 10010715
A85	CUI E19 C0005741
A86	UMLS-Preferred-Name E19 Blepharitis
A87	MEDDRA-PT E19 Blepharitis
A88	MEDDRA-PT-ID E19 10005148
A89	CUI E20 C0234632
A90	UMLS-Preferred-Name E20 Reduced visual acuity
A91	MEDDRA-PT E20 Visual acuity reduced
A92	MEDDRA-PT-ID E20 10047531
A93	CUI E21 C0259799
A94	UMLS-Preferred-Name E21 Punctate keratitis
A95	MEDDRA-PT E21 Punctate keratitis
A96	MEDDRA-PT-ID E21 10037508
A97	CUI E22 C0014236
A98	UMLS-Preferred-Name E22 Endophthalmitis
A99	MEDDRA-PT E22 Eye inflammation
A100	MEDDRA-PT-ID E22 10015943
A101	CUI E23 C0022081
A102	UMLS-Preferred-Name E23 Iritis
A103	MEDDRA-PT E23 Iritis
A104	MEDDRA-PT-ID E23 10022955
A105	CUI E24 C1328375
A106	UMLS-Preferred-Name E24 Application site discomfort
A107	MEDDRA-PT E24 Application site discomfort
A108	MEDDRA-PT-ID E24 10063072
A109	CUI E25 C0521490
A110	UMLS-Preferred-Name E25 Application site irritation
A111	MEDDRA-PT E25 Application site irritation
A112	MEDDRA-PT-ID E25 10003046
A113	CUI E26 C0423226
A114	UMLS-Preferred-Name E26 Corneal pigmentation
A115	MEDDRA-PT E26 Corneal pigmentation
A116	MEDDRA-PT-ID E26 10011040
A117	CUI E27 C0948285
A118	UMLS-Preferred-Name E27 Corneal striae
A119	MEDDRA-PT E27 Corneal striae
A120	MEDDRA-PT-ID E27 10052118
A121	CUI E28 C0014583
A122	UMLS-Preferred-Name E28 Episcleritis
A123	MEDDRA-PT E28 Episcleritis
A124	MEDDRA-PT-ID E28 10015084
A125	CUI E29 C0022281
A126	UMLS-Preferred-Name E29 Itching of eye
A127	MEDDRA-PT E29 Eye pruritus
A128	MEDDRA-PT-ID E29 10052140
A129	CUI E30 C1112366
A130	UMLS-Preferred-Name E30 Eyelid irritation
A131	MEDDRA-PT E30 Eyelid irritation
A132	MEDDRA-PT-ID E30 10057385
A133	CUI E31 C2138747
A134	UMLS-Preferred-Name E31 Crusting of eyelid
A135	MEDDRA-PT E31 Eyelid margin crusting
A136	MEDDRA-PT-ID E31 10052132
A137	CUI E32 C0423602
A138	UMLS-Preferred-Name E32 Foreign body sensation
A139	MEDDRA-PT E32 Sensation of foreign body
A140	MEDDRA-PT-ID E32 10061549
A141	CUI E33 C0152227
A142	UMLS-Preferred-Name E33 Excessive tearing
A143	MEDDRA-PT E33 Lacrimation increased
A144	MEDDRA-PT-ID E33 10023644
A145	CUI E34 C0271051
A146	UMLS-Preferred-Name E34 Macular retinal edema
A147	MEDDRA-PT E34 Macular oedema
A148	MEDDRA-PT-ID E34 10025415
A149	LLT E34 Macular edema
A150	LLT-ID E34 10054467
A151	CUI E35 C0423271
A152	UMLS-Preferred-Name E35 Scleral injection
A153	MEDDRA-PT E35 Scleral hyperaemia
A154	MEDDRA-PT-ID E35 10059096
A155	LLT E35 Scleral hyperemia
A156	LLT-ID E35 10059104
A157	CUI E36 C0042164
A158	UMLS-Preferred-Name E36 Uveitis
A159	MEDDRA-PT E36 Uveitis
A160	MEDDRA-PT-ID E36 10046851
A161	CUI E37 C0344232
A162	UMLS-Preferred-Name E37 Blurred vision
A163	MEDDRA-PT E37 Vision blurred
A164	MEDDRA-PT-ID E37 10047513
A165	LLT E37 Blurred vision
A166	LLT-ID E37 10005886
A167	CUI E38 C0235266
A168	UMLS-Preferred-Name E38 Eye irritation
A169	MEDDRA-PT E38 Eye irritation
A170	MEDDRA-PT-ID E38 10015946
A171	CUI E39 C0151827
A172	UMLS-Preferred-Name E39 Eye pain
A173	MEDDRA-PT E39 Eye pain
A174	MEDDRA-PT-ID E39 10015958
A175	CUI E40 C0018681
A176	UMLS-Preferred-Name E40 Headache
A177	MEDDRA-PT E40 Headache
A178	MEDDRA-PT-ID E40 10019211
A179	CUI E41 C0234708
A180	UMLS-Preferred-Name E41 Raised intraocular pressure
A181	MEDDRA-PT E41 Intraocular pressure increased
A182	MEDDRA-PT-ID E41 10022806
A183	CUI E42 C0022081
A184	UMLS-Preferred-Name E42 Iritis
A185	MEDDRA-PT E42 Iritis
A186	MEDDRA-PT-ID E42 10022955
A187	CUI E43 C0423193
A188	UMLS-Preferred-Name E43 Limbal hyperemia
A189	MEDDRA-PT E43 Ciliary hyperaemia
A190	MEDDRA-PT-ID E43 10052129
A191	LLT E43 Limbal hyperemia
A192	LLT-ID E43 10063468
A193	CUI E44 C1761613
A194	UMLS-Preferred-Name E44 Conjunctival hyperemia
A195	MEDDRA-PT E44 Conjunctival hyperaemia
A196	MEDDRA-PT-ID E44 10051625
A197	LLT E44 Conjunctival hyperemia
A198	LLT-ID E44 10054364
A199	CUI E45 C0259799
A200	UMLS-Preferred-Name E45 Punctate keratitis
A201	MEDDRA-PT E45 Punctate keratitis
A202	MEDDRA-PT-ID E45 10037508
A203	CUI E46 C0042164
A204	UMLS-Preferred-Name E46 Uveitis
A205	MEDDRA-PT E46 Uveitis
A206	MEDDRA-PT-ID E46 10046851
A207	CUI E47 C0423281
A208	UMLS-Preferred-Name E47 Anterior chamber flare
A209	MEDDRA-PT E47 Anterior chamber flare
A210	MEDDRA-PT-ID E47 10052127
A211	CUI E48 C0010037
A212	UMLS-Preferred-Name E48 Corneal edema
A213	MEDDRA-PT E48 Corneal oedema
A214	MEDDRA-PT-ID E48 10011033
A215	LLT E48 Corneal edema
A216	LLT-ID E48 10011007
A217	CUI E49 C0314719
A218	UMLS-Preferred-Name E49 Dryness of eye
A219	MEDDRA-PT E49 Dry eye
A220	MEDDRA-PT-ID E49 10013774
A221	CUI E50 C0022073
A222	UMLS-Preferred-Name E50 Iridocyclitis
A223	MEDDRA-PT E50 Iridocyclitis
A224	MEDDRA-PT-ID E50 10022941
A225	CUI E51 C0085636
A226	UMLS-Preferred-Name E51 Photophobia
A227	MEDDRA-PT E51 Photophobia
A228	MEDDRA-PT-ID E51 10034960
A229	CUI E52 C0234632
A230	UMLS-Preferred-Name E52 Reduced visual acuity
A231	MEDDRA-PT E52 Visual acuity reduced
A232	MEDDRA-PT-ID E52 10047531
A233	CUI E53 C1557306
A234	UMLS-Preferred-Name E53 Adverse Event Associated with Ocular and Visual Systems
A235	MEDDRA-PT E53 Eye symptom
A236	MEDDRA-PT-ID E53 10075536
